PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryMar 3, 2014	Integra LifeSciences to Participate in the Barclays Global Healthcare Conference in March PLAINSBORO, N.J., March 3, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conference next month: At 1:30 PM ET on Tuesday, March 11, 2014, Mr. Jack Henneman, Chief Financial Officer of Integra LifeSciences, will	View HTML Integra LifeSciences to Participate in the Barclays Global Healthcare Conference in March 10.3 KB
Toggle SummaryFeb 27, 2014	Integra LifeSciences Receives FDA Clearance for Integra(R) Titanium Bone Wedges PLAINSBORO, N.J., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of the Integra ® Titanium Bone Wedges, designed for internal fixation for bone fractures or osteotomies in the foot and ankle.	View HTML Integra LifeSciences Receives FDA Clearance for Integra(R) Titanium Bone Wedges 11.4 KB
Toggle SummaryFeb 25, 2014	Integra LifeSciences Appoints Kenneth Burhop, Ph.D., as Corporate Vice President and Chief Scientific Officer PLAINSBORO, N.J., Feb. 25, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Kenneth Burhop has joined Integra as Corporate Vice President, Chief Scientific Officer. Dr. Burhop will be responsible for setting Integra's strategic scientific vision	View HTML Integra LifeSciences Appoints Kenneth Burhop, Ph.D., as Corporate Vice President and Chief Scientific Officer 11.7 KB
Toggle SummaryFeb 25, 2014	Integra LifeSciences Reports Fourth Quarter 2013 Financial Results Increases Fourth Quarter Revenues 3% to $221 Million Introduces 2014 Full-Year Guidance PLAINSBORO, N.J., Feb. 25, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the fourth quarter ending December 31, 2013.	View HTML Integra LifeSciences Reports Fourth Quarter 2013 Financial Results 61.2 KB
Toggle SummaryFeb 10, 2014	Integra LifeSciences to Participate in the 2014 Citi Global and RBC Capital Markets Healthcare Conferences in February PLAINSBORO, N.J., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences next month: At 10:30 AM ET on Wednesday, February 26, 2014, Mr. Peter Arduini, President and Chief Executive Officer of	View HTML Integra LifeSciences to Participate in the 2014 Citi Global and RBC Capital Markets Healthcare Conferences in February 11 KB
Toggle SummaryJan 15, 2014	Integra LifeSciences Completes Acquisition of DuraSeal Product Lines From Covidien PLAINSBORO, N.J., Jan. 15, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has completed the acquisition of DuraSeal ® product lines from Covidien. Now, together with our DuraGen® family of grafts, Integra offers surgeons the largest	View HTML Integra LifeSciences Completes Acquisition of DuraSeal Product Lines From Covidien 11.7 KB
Toggle SummaryJan 13, 2014	Integra LifeSciences to Host Its Fourth Quarter 2013 Earnings Results Conference Call on February 25, 2014 PLAINSBORO, N.J., Jan. 13, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter 2013 financial results on Tuesday, February 25, 2014. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its Fourth Quarter 2013 Earnings Results Conference Call on February 25, 2014 9.9 KB
Toggle SummaryDec 30, 2013	Integra LifeSciences to Participate in the 32nd Annual J.P. Morgan Healthcare Conference PLAINSBORO, N.J., Dec. 30, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Mr. Peter Arduini, Integra's President and Chief Executive Officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Mr.	View HTML Integra LifeSciences to Participate in the 32nd Annual J.P. Morgan Healthcare Conference 10.5 KB
Toggle SummaryDec 23, 2013	Integra LifeSciences Announces Completion of Patient Enrollment in Clinical Study of Integra(R) Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers PLAINSBORO, N.J., Dec. 23, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has completed patient enrollment in a multi-center, randomized, controlled clinical trial comparing the safety and effectiveness of Integra ® Dermal Regeneration	View HTML Integra LifeSciences Announces Completion of Patient Enrollment in Clinical Study of Integra(R) Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers 13.2 KB
Toggle SummaryDec 12, 2013	Integra LifeSciences Announces NeuraGen(R) Clinical Study Published in Journal of Hand Surgery Compares Entubulation Versus Standard Microsurgical Technique for the Primary Repair of Median and Ulnar Nerve Injuries in the Forearm	View HTML